HelixBind
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1300 Massachusetts Ave Unit 103, Boxboro...Phone Number
(508) 460-1028Website
www.helixbind.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About HelixBind
HelixBind is transforming the diagnosis and management of bloodstream infections through its innovative diagnostic platform. The proprietary technology offers faster, more accurate microbiology results, enabling clinicians to identify invasive infections and tailor antimicrobial treatments for patients. By improving diagnostic speed and accuracy, HelixBind aims to reduce antimicrobial resistance and enhance patient outcomes. The company primarily serves healthcare providers dealing with sepsis and other bloodstream infections.Explore more
HelixBind Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HelixBind your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when HelixBind launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at HelixBind
HelixBind, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if HelixBind had a recent Job posting/layoffs
Earning: See what the market has to say on HelixBind recently announced quarterly report
Funding: Get notified immidiatlly once HelixBind has new funding data
Check if HelixBind has recently received funding, and reach out quickly before it becomes old news!
Check out if HelixBind is spiking on competitors!
Recommended Actions
Find VP level buyers at HelixBind
Find 2 more new buyers
Compare Similar Companies to HelixBind
Compare insights from companies similar to HelixBind, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HelixBind is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HelixBind is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HelixBind.
HelixBind financials insights
Gather financial insights about HelixBind, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Unspecified
$4M
2020
Debt
$150K
HelixBind Tech Stack
A closer look at the technologies used by HelixBind
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment
Funding
Project
Spending/Investment
Funding
HelixBind News & Media
FDA Grants HelixBind Breakthrough Device Designation for RaPID Sepsis Test
HelixBind’s device identifies the most common bloodstream infections associated with sepsis direct from blood and is designed to reduce time-to-diagnosis from days to hours HelixBind’s device identifies the most common bloodstream infections associated with sepsis direct from blood and is designed to reduce time-to-diagnosis from days to hoursHelixBind Awarded $3MM Grant from NIH for New Rapid Test for the Early Detection of Lyme Disease
HelixBind RaPID/Lyme test detects DNA from Borrelia directly from blood; clinical studies beginning now HelixBind RaPID/Lyme test detects DNA from Borrelia directly from blood; clinical studies beginning nowHelixBind Awarded $3MM Grant from NIH and Expands Clinical Advisory Board to Accelerate Development of Its Diagnostic Platform for Invasive Infections
COVID-19 crisis highlights need for faster diagnosis of secondary microbial infections; HelixBind’s platform designed to reduce time-to-diagnosis of bloodstream infections from days to hours, with much higher accuracy than currently possible COVID-19 crisis highlights need for faster diagnosis of secondary microbial infections; HelixBind’s platform designed to reduce time-to-diagnosis of bloodstream infections from days to hours, with much higher accuracy than currently possibleCARB-X supports expanded program for HelixBind's direct-detection platform for identifying and characterizing bloodstream infections
MARLBOROUGH, Mass., Dec. 9, 2019 /PRNewswire/ -- HelixBind, Inc. announced the expansion of its funding and support from CARB-X, (Combating Antibiotic Resistant Bacteria Accelerator), a global partnership funding the development of promising new antibacterial treatment, prevention and...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding HelixBind
Sign Up For FreeTo access detailed company insights
HelixBind is transforming the diagnosis and management of bloodstream infections through its innovative diagnostic platform. The proprietary technology offers faster, more accurate microbiology results, enabling clinicians to identify invasive infections and tailor antimicrobial treatments for patients. By improving diagnostic speed and accuracy, H... Read More
